Schizophrenia.com
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia
News
everhopeful
March 22, 2023, 2:13pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
Study Finds Higher-Dose Antipsychotic Polypharmacy Does Not Increase Hospitalization
News
0
230
May 3, 2023
Real-World Evidence of Antipsychotic Monotherapy Versus Polypharmacy in the Treatment of Schizophrenia Spectrum Disorders
News
0
107
March 15, 2024
Antipsychotic Polypharmacy vs Monotherapy
News
0
83
June 14, 2024
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
News
1
350
February 20, 2019
Antipsychotic polypharmacy and high-dose antipsychotic therapy compared to antipsychotic monotherapy at standard doses in schizophrenia - a systematic review
News
1
54
December 10, 2024